All individual numbers are from the SEC provided Financial Statement and Notes Data Sets. No guarantee is made for their accuracy. This report only shows the values that are common to a significant number of companies.
ALPHA TAU MEDICAL LTD. Last Reported: 6/30/2023 Stock Symbol: DRTS

Business Address

KIRYAT HAMADA 5

JERUSALEM , IL 9777605

Mailing Address

KIRYAT HAMADA 5

JERUSALEM , IL 9777605
Phone Number: 972-3-577-4115 / State Incorporated: / Fiscal Year End 12 /31

Balance Sheet

Date 6/30/2023 12/31/2022 6/30/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018
Cash and Cash Equivalents $855,000.00 $5,836,000.00 $11,571,000.00 $23,236,000.00 $15,598,000.00 -- --
Accounts Receivable Net Current -- -- -- -- -- -- --
Inventory -- -- -- -- -- -- --
Prepaid Expenses and Other Current Assets $1,698,000.00 $1,097,000.00 $3,199,000.00 $707,000.00 $864,000.00 -- --
Total Current Assets $96,059,000.00 $106,477,000.00 $116,027,000.00 $32,641,000.00 $47,455,000.00 -- --
Property Plant and Equipement $7,549,000.00 $7,471,000.00 $7,746,000.00 $7,546,000.00 $5,395,000.00 -- --
Intangible Assets Net -- -- -- -- -- -- --
Goodwill -- -- -- -- -- -- --
Other Assets $15,147,000.00 -- -- -- -- -- --
Total Assets $111,206,000.00 $120,149,000.00 $123,980,000.00 $42,215,000.00 $52,989,000.00 -- --
Accounts Payable $1,789,000.00 $1,423,000.00 $1,197,000.00 $1,203,000.00 $964,000.00 -- --
Accrued Liabilities -- $1,276,000.00 -- $2,366,000.00 $551,000.00 -- --
Total Current Liabilities $18,643,000.00 $14,492,000.00 $15,712,000.00 $23,028,000.00 $7,454,000.00 -- --
Long Term Debt -- -- -- -- -- -- --
Additional Paid-in Capital -- -- -- -- -- -- --
Accumulated Other Comprehensive Loss -- -- -- -- -- -- --
Accumulated Deficit $-103,482,000.00 $-86,602,000.00 $-80,583,000.00 $-52,840,000.00 $-25,569,000.00 -- --
Total Stockholders' Equity $92,563,000.00 $105,657,000.00 $108,268,000.00 $-34,777,000.00 $-8,429,000.00 $-193,000.00 $1,861,000.00
Controlling Interest in Subsidiaries -- -- -- -- -- -- --
Total Liabilities and Equity $111,206,000.00 $120,149,000.00 $123,980,000.00 $42,215,000.00 $52,989,000.00 -- --

Statement of Operations

Date 6/30/2023 12/31/2022 6/30/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018
Total Revenues -- -- -- -- -- -- --
Cost of Revenues -- -- -- -- -- -- --
Gross Profit -- -- -- -- -- -- --
Research and Development $12,261,000.00 $20,890,000.00 $10,683,000.00 $11,447,000.00 $7,544,000.00 $6,636,000.00 --
Selling, General, and Administrative -- -- -- -- -- -- --
Total Operating Expenses -- -- -- -- -- -- --
Loss from Operations $-16,812,000.00 $-32,136,000.00 $16,793,000.00 $13,790,000.00 $9,244,000.00 $8,010,000.00 --
Loss Before Income Taxes $-16,833,000.00 $-33,742,000.00 $27,735,000.00 $27,264,000.00 $8,724,000.00 $8,318,000.00 --
Earnings Per Share Basic $-0.24 $-0.53 $-0.48 $-0.67 $-0.22 $-0.25 --
Weighted Average Shares Basic 69,262,381 63,534,875 58,023,875 40,534,697 40,274,935 33,815,448 --
Earnings Per Share Diluted $-0.24 $-0.53 $-0.48 $-0.67 $-0.22 $-0.25 --
Weighted Average Shares Diluted 69,262,381 63,534,875 58,023,875 40,534,697 40,274,935 33,815,448 --
Common Stock Shares Authorized 362,116,800 362,116,800 362,116,800 72,423,360 72,423,360 -- --
Common Stock Shares Outstanding 69,373,135 69,105,000 68,575,397 40,528,913 40,433,578 -- --
Common Stock Value -- -- -- -- -- -- --
Common Stock Par Or Stated Value Per Share -- -- -- -- -- -- --
Payments Of Dividends Common Stock -- -- -- -- -- -- --
Preferred Stock Shares Authorized -- -- -- -- -- -- --
Preferred Stock Shares Outstanding -- -- -- -- -- -- --
Preferred Stock Value -- -- -- -- -- -- --
Preferred Stock Par Or Stated Value Per Share -- -- -- -- -- -- --
Share Price -- -- -- -- -- -- --
Copyright 2024 PursePoor.com